Social Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Social Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Reducing Social Avoidance Among Adolescents With Special Educational Needs [NA]
Clinical trial update from The Hong Kong Polytechnic University focusing on reducing social avoidance and social anxiety in adolescents with…
-
FDA approval · 2024-06-06FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' Venlafaxine hydrochloride as an original-application generic (ANDA 217767). Venlafaxine HCl is indicat…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: SOPHIE: Online-intervention for Prevention and Treatment of Social Anxiety in Adolescents [NA]
The SOPHIE online-intervention trial for prevention and treatment of social anxiety in adolescents has completed (status: COMPLETED).
-
CLINICAL_TRIALS research · 2024-05-24Clinical Trial Update: Virtual Reality Exposure for Public Speaking Anxiety [NA]
A clinical trial from Vilnius University is evaluating virtual reality exposure therapy to treat public speaking anxiety and is currently re…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Changing the Course of Social Anxiety in Adolescence [NA]
This update notes the completion of a clinical trial led by the University of Coimbra evaluating treatment for social anxiety disorder in ad…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Optimizing Cognitive-behavioral Therapy for Social Anxiety Disorder Using the Factorial Design [NA]
A completed clinical trial from the University of Bern evaluating optimized cognitive-behavioral therapy approaches for Social Anxiety Disor…
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: UniVRse: VR-CBT for Students With Social Anxiety [NA]
UniVRse VR-CBT trial for students with social anxiety is currently recruiting. The sponsor is the University of Surrey.
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Clinical Trial of a Group Self-management Support Program for Anxiety Disorders [NA]
The trial is active but not recruiting for a group self-management support program targeting anxiety disorders, with listed conditions inclu…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Text Message Safety Behavior Fading for Appearance Concerns [NA]
A completed clinical trial evaluating a text message-based safety behavior fading intervention for appearance concerns in body dysmorphic di…
-
FDA approval · 2024-03-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride from Camber Pharmaceuticals, approving a new supplement to an existing…
-
FDA approval · 2024-02-02FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for sertraline hydrochloride from Rising Pharma Holdings, Inc., resulting in approval of a gener…
-
FDA approval · 2024-01-30FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride from Epic Pharma, LLC, supporting the approval of a generic produc…
-
FDA approval · 2024-01-19FDA Approved: PAROXETINE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Paroxetine by ANI Pharmaceuticals, Inc., indicating approval of a generic product under ANDA 215…
-
CLINICAL_TRIALS trial_result · 2024-01-08Clinical Trial Update: Attention, Teleconferencing and Social Anxiety [NA]
Clinical trial update for social anxiety disorder with completed status; results posted.
-
FDA approval · 2024-01-03FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for venlafaxine hydrochloride from Aurobindo Pharma Limited, confirming approval of the generic prod…
-
FDA approval · 2023-11-21FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for venlafaxine hydrochloride extended-release (Chartwell RX, LLC), reflecting an approved update to…
-
FDA approval · 2023-11-21FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride from Granules Pharmaceuticals Inc., authorizing an additional form…
-
FDA approval · 2023-11-01FDA Approved: VENLAFAXINE — Supplemental Application (Zydus Lifesciences Limited)
FDA granted supplemental approval for venlafaxine from Zydus Lifesciences Limited, signaling an approved modification to an existing generic…
-
FDA approval · 2023-09-22FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for sertraline hydrochloride from Granules Pharmaceuticals Inc. The action confirms continued approv…
-
FDA approval · 2023-08-21FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Venlafaxine from BluePoint Laboratories, confirming a generic venlafaxine product (venlafaxine h…
-
FDA approval · 2023-08-21FDA Approved: VENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for Venlafaxine from Sun Pharmaceutical Industries, Inc., updating the generic product under ANDA 07…
-
FDA approval · 2023-08-18FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for sertraline hydrochloride (generic) manufactured by Mylan Pharmaceuticals Inc.
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for venlafaxine hydrochloride, a generic antidepressant.
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
FDA approved a supplemental application for venlafaxine hydrochloride by Vertical Pharmaceuticals, LLC.
-
FDA label_change · 2023-08-18FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved a supplemental application for venlafaxine from Alembic Pharmaceuticals, resulting in labeling updates for the generic prod…